Phase II trial of RVX-208 in patients with mild cognitive impairment
Latest Information Update: 10 Apr 2013
At a glance
- Drugs Apabetalone (Primary)
- Indications Alzheimer's disease; Cognition disorders
- Focus Therapeutic Use
- 10 Apr 2013 New trial record